Choice Personal Care Theraputic Blue Ice

Description

CHOICE PERSONAL CARE THERAPUTIC BLUE ICE is a pain-relieving analgesic gel formulated for topical application. This product is designed to provide targeted relief from discomfort associated with various conditions. The gel's formulation allows for effective penetration and absorption, delivering therapeutic benefits directly to the affected area.

Uses and Indications

This drug is indicated for the temporary relief of minor pains of muscles and joints associated with conditions such as simple back ache, arthritis, sprains, strains, or bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the affected skin area should be cleaned thoroughly prior to application. The medication may be applied no more than 3 to 4 times daily. There is no need for a protective cover after application.

The medication can be used in conjunction with ice packs to enhance its effects. Additionally, it may be applied under a wet or dry bandage; however, it is important to ensure that the bandage is wrapped loosely to avoid excessive pressure on the skin.

For children under 2 years of age, it is advised to consult a healthcare professional before use.

Contraindications

Use of this product is contraindicated in the following situations:

Internal use is prohibited. The product should not be applied with heating pads or other heating devices, as this may lead to adverse effects. Additionally, application on wounds or damaged skin is contraindicated due to the potential for irritation or further injury.

Warnings and Precautions

For external use only; contact with eyes should be strictly avoided. This product is contraindicated for internal use, application with heating pads or devices, and should not be applied to wounds or damaged skin.

Healthcare professionals should advise patients to consult a doctor prior to use if they have sensitive skin. It is imperative that the product is used only as directed. Patients should be cautioned against tightly bandaging the area of application and must avoid contact with eyes and mucous membranes.

In the case of pregnancy or breastfeeding, it is recommended that individuals seek guidance from a health professional before using this product.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is advised.

Side Effects

Patients should be aware of several important warnings and precautions associated with the use of this product. It is intended for external use only, and contact with the eyes should be strictly avoided. The product should not be used internally, with heating pads or devices, or on wounds or damaged skin.

Before using this product, patients are advised to consult a healthcare professional if they have sensitive skin. During use, it is crucial to follow the directions provided, avoid tight bandaging, and prevent contact with the eyes and mucous membranes.

For pregnant or breastfeeding individuals, it is recommended to seek advice from a health professional prior to use. Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a poison control center immediately.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Choice Personal Care Theraputic Blue Ice (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to clean skin thoroughly, not exceeding 3-4 applications per day. It is not necessary to use a protective cover. For children under 2 years of age, consultation with a doctor is advised prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy and lactation has not been established, and potential risks to fetal outcomes or nursing infants are not fully characterized. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks associated with the use of this medication during these critical periods.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to mitigate potential risks associated with overdosage.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Monitoring for any adverse effects is essential, and appropriate management should be initiated based on the clinical presentation.

Management procedures may include supportive care and symptomatic treatment, tailored to the specific symptoms exhibited by the patient. Continuous assessment and monitoring are recommended to ensure patient safety and effective intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients must be informed that the medication is for external use only and should not be used internally. They should also be cautioned against using the medication in conjunction with heating pads or other heating devices, as this may lead to adverse effects. Additionally, patients should be advised not to apply the medication on wounds or damaged skin to avoid complications.

It is essential to emphasize that patients should use the medication only as directed and avoid bandaging the area tightly after application. Healthcare providers should also remind patients to avoid contact with the eyes and mucous membranes, as this could cause irritation.

Finally, patients with sensitive skin should be encouraged to consult their healthcare provider before using the medication to ensure it is appropriate for their condition.

Storage and Handling

The product is supplied in a tightly sealed container to ensure its integrity. It should be stored at a temperature range of 59-85°F (15-30°C). Care should be taken to keep the container tightly closed at all times. Additionally, it is imperative to avoid using, pouring, spilling, or storing the product near heat sources or open flames to maintain safety and efficacy.

Additional Clinical Information

The product is administered topically and is indicated for use in adults and children aged 2 years and older, with a recommended application frequency of no more than 3-4 times daily. Clinicians should counsel patients that the product is for external use only and must not come into contact with the eyes. It should not be used internally, with heating pads or devices, or on wounds or damaged skin. Patients are advised to consult a healthcare professional prior to use if they have sensitive skin, are pregnant, or are breastfeeding. Additionally, the product should be kept out of reach of children, and in the event of accidental ingestion, medical assistance or contact with a poison control center is necessary.

Drug Information (PDF)

This file contains official product information for Choice Personal Care Theraputic Blue Ice, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)